Introduction: Ovarian follicle growth is a key step in the success of assisted reproductive treatment, but limited data exists to directly relate follicle growth to recombinant FSH (rFSH) dose. In this study, we aim to evaluate FSH requirements for follicular growth during controlled ovarian stimulation. Method: Single centre retrospective cohort study of 1,034 IVF cycles conducted between January 2012-January 2016 at Hammersmith Hospital IVF unit, London, UK. Median follicle size after five days of stimulation with rFSH and the proportion of antral follicles recruited were analysed in women treated with rFSH alone to induce follicular growth during IVF treatment. Results: Starting rFSH dose adjusted for body weight (iU/kg) predicted serum ...
The aim of this study was to compare the costs and effects of two different controlled ovarian hyper...
In IVF/ICSI, exogenous FSH is administered (ovarian hyperstimulation) in order to achieve multi-foll...
ObjectiveTo evaluate the dose–response relationship of a novel recombinant human FSH (rhFSH; FE 9990...
Introduction: Ovarian follicle growth is a key step in the success of assisted reproductive treatmen...
Objectives: To evaluate whether serum follicle stimulating hormone (FSH) level during the early cont...
Current ovarian stimulation regimens for IVF are complex and not without risk. Increasing ...
Objective: To study the association between serum anti-Mullerian hormone (AMH) levels and follicular...
The art of ovarian stimulation for IVF/ICSI treatment using exogenous FSH should be balanced against...
Background: Individualization of the follicle-stimulating hormone (FSH) starting dose is considered ...
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle coun
Background: Controlled ovarian hyperstimulation aims to obtain mature follicles. The present study w...
Objective: To compare two dosages of recombinant human follicle-stimulating hormone for controlled o...
Abstract Background When stimulating a patient with p...
AbstractIntroductionControlled ovarian stimulation is an essential part of in vitro fertilization (I...
Purpose: Down-regulation with gonadodropin-releasing agonist (GnRH-a) protocol during IVF stimulatio...
The aim of this study was to compare the costs and effects of two different controlled ovarian hyper...
In IVF/ICSI, exogenous FSH is administered (ovarian hyperstimulation) in order to achieve multi-foll...
ObjectiveTo evaluate the dose–response relationship of a novel recombinant human FSH (rhFSH; FE 9990...
Introduction: Ovarian follicle growth is a key step in the success of assisted reproductive treatmen...
Objectives: To evaluate whether serum follicle stimulating hormone (FSH) level during the early cont...
Current ovarian stimulation regimens for IVF are complex and not without risk. Increasing ...
Objective: To study the association between serum anti-Mullerian hormone (AMH) levels and follicular...
The art of ovarian stimulation for IVF/ICSI treatment using exogenous FSH should be balanced against...
Background: Individualization of the follicle-stimulating hormone (FSH) starting dose is considered ...
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle coun
Background: Controlled ovarian hyperstimulation aims to obtain mature follicles. The present study w...
Objective: To compare two dosages of recombinant human follicle-stimulating hormone for controlled o...
Abstract Background When stimulating a patient with p...
AbstractIntroductionControlled ovarian stimulation is an essential part of in vitro fertilization (I...
Purpose: Down-regulation with gonadodropin-releasing agonist (GnRH-a) protocol during IVF stimulatio...
The aim of this study was to compare the costs and effects of two different controlled ovarian hyper...
In IVF/ICSI, exogenous FSH is administered (ovarian hyperstimulation) in order to achieve multi-foll...
ObjectiveTo evaluate the dose–response relationship of a novel recombinant human FSH (rhFSH; FE 9990...